Similar articles

• Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.

  Brötz-Oesterhelt H, Beyer D, Kroll HP, Endermann R, Ladel C, Schroeder W, Hinzen B, Raddatz S, Paulsen H, Henninger K, Bandow JE, Sahl HG, Labischinski H. Brötz-Oesterhelt H, et al. Nat Med. 2005 Oct;11(10):1082-7. doi: 10.1038/nm1306. Epub 2005 Oct 2. Nat Med. 2005. PMID: 16200071
• An increased level of alternative sigma factor RpoS partially suppresses drug hypersensitivity associated with inactivation of the multidrug resistance pump AcrAB in Escherichia coli.

  Rami A, Toutain CM, Jacq A. Rami A, et al. Res Microbiol. 2005 Apr;156(3):356-60. doi: 10.1016/j.resmic.2004.10.015. Epub 2005 Jan 27. Res Microbiol. 2005. PMID: 15808939
• ClpP Protease, a Promising Antimicrobial Target.

  Moreno-Cinos C, Goossens K, Salado IG, Van Der Veken P, De Winter H, Augustyns K. Moreno-Cinos C, et al. Int J Mol Sci. 2019 May 7;20(9):2232. doi: 10.3390/ijms20092232. Int J Mol Sci. 2019. PMID: 31067645 Free PMC article. Review.
• Multiple attack on bacteria by the new antibiotic teixobactin.

  von Nussbaum F, Süssmuth RD. von Nussbaum F, et al. Angew Chem Int Ed Engl. 2015 Jun 1;54(23):6684-6. doi: 10.1002/anie.201501440. Epub 2015 May 12. Angew Chem Int Ed Engl. 2015. PMID: 25968231 No abstract available.
• Conformational control of the bacterial Clp protease by natural product antibiotics.

  Malik IT, Brötz-Oesterhelt H. Malik IT, et al. Nat Prod Rep. 2017 Jul 6;34(7):815-831. doi: 10.1039/c6np00125d. Nat Prod Rep. 2017. PMID: 28375422 Review.